Spots Global Cancer Trial Database for childhood
Every month we try and update this database with for childhood cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer | NCT05106296 | Ependymoma Medulloblastoma Glioblastoma Primary Brain T... | Ibrutinib Indoximod Cyclophosphamid... Etoposide | 12 Years - 25 Years | Augusta University | |
| Genomic Changes in Childhood Acute Lymphoblastic Leukemia | NCT01089907 | Acute Lymphobla... | 1 Day - 18 Years | National Taiwan University Hospital | ||
| AC220 for Children With Relapsed/Refractory ALL or AML | NCT01411267 | Lymphoblastic L... Myelogenous Leu... | AC220 Cytarabine Etoposide Methotrexate | 1 Month - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Rehabilitation Including Social and Physical Activity in Children and Teenagers With Cancer | NCT01772862 | Childhood Cance... | Intervention gr... | 6 Years - 18 Years | Rigshospitalet, Denmark | |
| Rehabilitation Including Social and Physical Activity in Children and Teenagers With Cancer | NCT01772862 | Childhood Cance... | Intervention gr... | 6 Years - 18 Years | Rigshospitalet, Denmark | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) | NCT00440726 | Acute Lymphobla... | Bortezomib Dexamethasone PEG-asparaginas... Doxorubicin Cytarabine Methotrexate Vincristine Triple IT Thera... | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML | NCT05622591 | Acute Myeloid L... AML, Childhood Relapsed Pediat... Refractory Pedi... | ELU001 | 1 Month - 9 Years | Elucida Oncology | |
| Vinorelbine for Recurrent ALCL-2017 | NCT03443128 | Anaplastic Larg... Vinorelbine | Vinorelbine | - 18 Years | Children's Cancer Group, China | |
| A Study Of Panobinostat In Children With Refractory Hematologic Malignancies | NCT01321346 | Lymphoblastic L... Myelogenous Leu... Hodgkin's Disea... Non-Hodgkin's L... | Panobinostat Cytarabine Panobinostat | 8 Years - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer | NCT05106296 | Ependymoma Medulloblastoma Glioblastoma Primary Brain T... | Ibrutinib Indoximod Cyclophosphamid... Etoposide | 12 Years - 25 Years | Augusta University | |
| Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults | NCT02496520 | Sarcoma Central Nervous... | dendritic cells Surgery as need... Chemotherapy as... Radiation thera... | 3 Years - 40 Years | Clinica Universidad de Navarra, Universidad de Navarra | |
| Prospective Trial of Vaccine Responses in Childhood Cancer Survivors | NCT00505063 | Childhood Cance... Multiple Diseas... | Immunization Sc... Immunization Sc... Immunization Sc... | 2 Years - 18 Years | Memorial Sloan Kettering Cancer Center | |
| A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL | NCT01483690 | Acute Lymphobla... Precursor B-Cel... Precursor T-Cel... | Decitabine Vorinostat Vincristine Dexamethasone Mitoxantrone Pegaspargase Methotrexate | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents | NCT02352389 | Influenza, Huma... | Blood sample Nasal swab Oropharyngeal s... Stool sample Symptom checkli... | - 21 Years | St. Jude Children's Research Hospital | |
| Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment | NCT05774990 | Leukemia, Myelo... Acute Lymphobla... | - 17 Years | University of Southern Denmark | ||
| Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae | NCT04541056 | Childhood Non-H... Childhood Acute... Childhood Acute... | Goal Management... Brain Health Wo... | 18 Years - 40 Years | Norwegian University of Science and Technology | |
| Rehabilitation Including Social Activity and Education in Children and Teenagers With Cancer | NCT01772849 | Childhood Cance... | Intervention gr... | 6 Years - 18 Years | Rigshospitalet, Denmark | |
| Vinorelbine for Recurrent ACLC | NCT03397953 | Anaplastic Larg... Vinorelbine | Vinorelbine | - 18 Years | Children's Cancer Group, China | |
| Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia | NCT01743807 | Relapsed Acute ... Relapsed Acute ... | GNKG168 | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma | NCT01614197 | Lymphoblastic L... Lymphoblastic L... Peripheral T-ce... | Temsirolimus Etoposide Cyclophosphamid... Methotrexate Hydrocortisone Cytarabine | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Vinorelbine for Recurrent ACLC | NCT03397953 | Anaplastic Larg... Vinorelbine | Vinorelbine | - 18 Years | Children's Cancer Group, China | |
| Early Life Exposures in Agriculture | NCT02743481 | Testicular Canc... Leukemia Lymphoma Brain Cancer | 7 Years - 46 Years | National Institutes of Health Clinical Center (CC) | ||
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | NCT03643276 | Acute Lymphobla... | Blinatumomab Bortezomib Cyclophosphamid... Cytarabine Daunorubicin Myocet Dexamethasone Doxorubicin Etoposide Fludarabine Pho... Ifosfamide 6-Mercaptopurin... Methotrexate Pegaspargase Prednisolone Tioguanin Vincristine Vindesine Erwinase | - 17 Years | University Hospital Schleswig-Holstein | |
| Prospective Trial of Vaccine Responses in Childhood Cancer Survivors | NCT00505063 | Childhood Cance... Multiple Diseas... | Immunization Sc... Immunization Sc... Immunization Sc... | 2 Years - 18 Years | Memorial Sloan Kettering Cancer Center | |
| A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL | NCT01483690 | Acute Lymphobla... Precursor B-Cel... Precursor T-Cel... | Decitabine Vorinostat Vincristine Dexamethasone Mitoxantrone Pegaspargase Methotrexate | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| AC220 for Children With Relapsed/Refractory ALL or AML | NCT01411267 | Lymphoblastic L... Myelogenous Leu... | AC220 Cytarabine Etoposide Methotrexate | 1 Month - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Rehabilitation Including Social Activity and Education in Children and Teenagers With Cancer | NCT01772849 | Childhood Cance... | Intervention gr... | 6 Years - 18 Years | Rigshospitalet, Denmark | |
| Vaccination for Children of H&O and Their Parents | NCT03373656 | Vaccination Hematologic Mal... Solid Tumor, Ch... | Vaccination No Vaccination | - 18 Years | Children's Cancer Group, China | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| AC220 for Children With Relapsed/Refractory ALL or AML | NCT01411267 | Lymphoblastic L... Myelogenous Leu... | AC220 Cytarabine Etoposide Methotrexate | 1 Month - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML | NCT01861002 | Lymphoblastic L... Myelogenous Leu... | Azacytidine Fludarabine Cytarabine Intrathecal (IT... Intrathecal Met... | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment | NCT05774990 | Leukemia, Myelo... Acute Lymphobla... | - 17 Years | University of Southern Denmark | ||
| A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents | NCT02352389 | Influenza, Huma... | Blood sample Nasal swab Oropharyngeal s... Stool sample Symptom checkli... | - 21 Years | St. Jude Children's Research Hospital | |
| Use of Virtual Reality for Surgical Planning in Neuroblastoma | NCT05781919 | Neuroblastoma | Immersive virtu... Gold standard i... | - 18 Years | Hospital Sant Joan de Deu |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
